The real drug development delay? Bad communication.

The European Commission is concerned that diverging policies in member states could derail the European Union's Strategy for Life Sciences and Biotechnology. The concern is expressed in the Commission ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Every biotech lab in the world leaks money in a silent way. Through lost time. Not broken equipment or failed experiments, but from something far less visible: information that exists somewhere in the ...

When I first saw the AdCom briefing documents for Legend Biotech’s (LEGN) and Johnson & Johnson’s (JNJ) Carvykti, I thought the stock would surely plunge. But that is not what happened and there was ...